Early Changes of Neuromuscular Transmission in the SOD1(G93A) Mice Model of ALS Start Long before Motor Symptoms Onset

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Rocha, Mariana C ^a,b,d   Pousinha, Paula A ^a,b,e   Correia, Alexandra M ^a,b,c   Sebastião, Ana M ^a,b   Ribeiro, Joaquim A ^a,b  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^b UNIVERSITY OF LISBON   (Portugal)

^c Museu Nacional de Historia Natural Universidade de Lisboa   (Portugal)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

^e INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; COPPER ZINC SUPEROXIDE DISMUTASE;

ACETYLCHOLINE RELEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; DIAPHRAGM MUSCLE; ENDPLATE POTENTIAL; FEMALE; GIANT MINIATURE ENDPLATE POTENTIAL; MALE; MINIATURE ENDPLATE POTENTIAL; MOUSE; MUSCLE DENERVATION; MUSCLE REINNERVATION; NERVE ENDING; NEUROMUSCULAR SYNAPSE; NEUROMUSCULAR TRANSMISSION; NONHUMAN; SYNAPTIC TRANSMISSION;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; DIAPHRAGM; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MALE; MICE; MICE, TRANSGENIC; MOTOR ACTIVITY; MUSCLE, SKELETAL; NEUROMUSCULAR JUNCTION; SUPEROXIDE DISMUTASE; SYNAPTIC POTENTIALS; SYNAPTIC TRANSMISSION; TIME FACTORS;

EID: 84883533237     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0073846     Document Type: Article

References (50)

1. Boillée S, Vande Velde C, Cleveland DW, (2006) ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 52: 39-59. doi:10.1016/j.neuron.2006.09.018. PubMed: 17015226.
2. Ferraiuolo L, Kirby J, Grierson AJ, Sendtner M, Shaw PJ, (2011) Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis. Nat Rev Neurol 7: 616-630. doi:10.1038/nrneurol.2011.152. PubMed: 22051914.
3. Frey D, Schneider C, Xu L, Borg J, Spooren W, et al. (2000) Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. J Neurosci 20: 2534-2542. PubMed: 10729333.
4. Hegedus J, Putman CT, Gordon T, (2007) Time course of preferential motor unit loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis. Neurobiol Dis 28: 154-164. doi:10.1016/j.nbd.2007.07.003. PubMed: 17766128.
5. Hegedus J, Putman CT, Tyreman N, Gordon T, (2008) Preferential motor unit loss in the SOD1 G93A transgenic mouse model of amyotrophic lateral sclerosis. J Physiol 586: 3337-3351. doi:10.1113/jphysiol.2007.149286. PubMed: 18467368.
6. Marcuzzo S, Zucca I, Mastropietro A, de Rosbo NK, Cavalcante P, et al. (2011) Hind limb muscle atrophy precedes cerebral neuronal degeneration in G93A-SOD1 mouse model of amyotrophic lateral sclerosis: a longitudinal MRI study. Exp Neurol 231: 30-37. doi:10.1016/j.expneurol.2011.05.007. PubMed: 21620832.
7. Kim YI, [!(surname)!], Cheng CC, Davis CE, O'Shaughnessy TJ, (1996) Neuromuscular transmission in a transgene animal model of motor neuron disease. In Proceedings of the 18th Annual International Conference. In of the IEEE Amsterdam, Netherlands: Engineering in Medicine and Biology Society, pp. 6.2.8: Physiological Modelling- Neuromuscular General: 173-174.
8. Naumenko N, Pollari E, Kurronen A, Giniatullina R, Shakirzyanova A, et al. (2011) Gender-Specific Mechanism of Synaptic Impairment and Its Prevention by GCSF in a Mouse Model of ALS. Front Cell Neurosci 5: 26. PubMed: 22180738.
9. Souayah N, Coakley KM, Chen R, Ende N, McArdle JJ, (2012) Defective neuromuscular transmission in the SOD1 G93A transgenic mouse improves after administration of human umbilical cord blood cells. Stem Cell Rev 8: 224-228. doi:10.1007/s12015-011-9281-3. PubMed: 21678037.
10. Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, et al. (1994) Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264: 1772-1775. doi:10.1126/science.8209258. PubMed: 8209258.
11. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, et al. (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362: 59-62. doi:10.1038/362059a0. PubMed: 8446170.
12. Rozas G, Guerra MJ, Labandeira-García JL, (1997) An automated rotarod method for quantitative drug-free evaluation of overall motor deficits in rat models of parkinsonism. Brain Res Brain Res Protoc 2: 75-84. doi:10.1016/S1385-299X(97)00034-2. PubMed: 9438075.
13. Zhang W, Narayanan M, Friedlander RM, (2003) Additive neuroprotective effects of minocycline with creatine in a mouse model of ALS. Ann Neurol 53: 267-270. doi:10.1002/ana.10476. PubMed: 12557297.
14. Pousinha PA, Correia AM, Sebastião AM, Ribeiro JA, (2012) Neuromuscular transmission modulation by adenosine upon aging. Neurobiol Aging 33: 2869-2880. doi:10.1016/j.neurobiolaging.2012.01.008. PubMed: 22365485.
15. Ribeiro JA, Sebastião AM, (1987) On the role, inactivation and origin of endogenous adenosine at the frog neuromuscular junction. J Physiol 384: 571-585. PubMed: 2821240.
16. Ribeiro JA, Walker J, (1975) The effects of adenosine triphosphate and adenosine diphosphate on transmission at the rat and frog neuromuscular junctions. Br J Pharmacol 54: 213-218. doi:10.1111/j.1476-5381.1975.tb06931.x. PubMed: 167894.
17. Cruz LJ, Gray WR, Olivera BM, Zeikus RD, Kerr L, et al. (1985) Conus geographus toxins that discriminate between neuronal and muscle sodium channels. J Biol Chem 260: 9280-9288. PubMed: 2410412.
18. Gillingwater TH, Thomson D, Mack TG, Soffin EM, Mattison RJ, et al. (2002) Age-dependent synapse withdrawal at axotomised neuromuscular junctions in Wld(s) mutant and Ube4b/Nmnat transgenic mice. J Physiol 543: 739-755. doi:10.1113/jphysiol.2002.022343. PubMed: 12231635.
19. Pardo NE, Hajela RK, Atchison WD, (2006) Acetylcholine release at neuromuscular junctions of adult tottering mice is controlled by N-(cav2.2) and R-type (cav2.3) but not L-type (cav1.2) Ca2+ channels. J Pharmacol Exp Ther 319: 1009-1020. doi:10.1124/jpet.106.108670. PubMed: 16982704.
20. Rozas JL, Gómez-Sánchez L, Tomás-Zapico C, Lucas JJ, Fernández-Chacón R, (2011) Increased neurotransmitter release at the neuromuscular junction in a mouse model of polyglutamine disease. J Neurosci 31: 1106-1113. doi:10.1523/JNEUROSCI.2011-10.2011. PubMed: 21248135.
21. Sons MS, Plomp JJ, (2006) Rab3A deletion selectively reduces spontaneous neurotransmitter release at the mouse neuromuscular synapse. Brain Res 1089: 126-134. doi:10.1016/j.brainres.2006.03.055. PubMed: 16631140.
22. Kelly SS, (1978) The effect of age on neuromuscular transmission. J Physiol 274: 51-62. PubMed: 203677.
23. Wood SJ, Slater CR, (2001) Safety factor at the neuromuscular junction. Prog Neurobiol 64: 393-429. doi:10.1016/S0301-0082(00)00055-1. PubMed: 11275359.
24. Sellin LC, Molgó J, Törnquist K, Hansson B, Thesleff S, (1996) On the possible origin of giant or slow-rising miniature end-plate potentials at the neuromuscular junction. Pflugers Arch 431: 325-334. doi:10.1007/BF02207269. PubMed: 8584425.
25. Colméus C, Gomez S, Molgó J, Thesleff S, (1982) Discrepancies between spontaneous and evoked synaptic potentials at normal, regenerating and botulinum toxin poisoned mammalian neuromuscular junctions. Proc R Soc Lond B Biol Sci 215: 63-74. doi:10.1098/rspb.1982.0028. PubMed: 6127697.
26. Thesleff S, Molgó J, Lundh H, (1983) Botulinum toxin and 4-aminoquinoline induce a similar abnormal type of spontaneous quantal transmitter release at the rat neuromuscular junction. Brain Res 264: 89-97. doi:10.1016/0006-8993(83)91123-X. PubMed: 6133583.
27. Rizzoli SO, Betz WJ, (2005) Synaptic vesicle pools. Nat Rev Neurosci, 6: 57-69. doi:10.1038/nrn1583. PubMed: 15611727.
28. Jaiswal MK, Zech WD, Goos M, Leutbecher C, Ferri A, et al. (2009) Impairment of mitochondrial calcium handling in a mtSOD1 cell culture model of motoneuron disease. BMC Neurosci 10: 64. doi:10.1186/1471-2202-10-S1-P64. PubMed: 19545440.
29. Kong J, Xu Z, (1998) Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1. J Neurosci 18: 3241-3250. PubMed: 9547233.
30. Damiano M, Starkov AA, Petri S, Kipiani K, Kiaei M, et al. (2006) Neural mitochondrial Ca2+ capacity impairment precedes the onset of motor symptoms in G93A Cu/Zn-superoxide dismutase mutant mice. J Neurochem 96: 1349-1361. doi:10.1111/j.1471-4159.2006.03619.x. PubMed: 16478527.
31. Nguyen KT, García-Chacón LE, Barrett JN, Barrett EF, David G, (2009) The Psi(m) depolarization that accompanies mitochondrial Ca2+ uptake is greater in mutant SOD1 than in wild-type mouse motor terminals. Proc Natl Acad Sci U S A 106: 2007-2011. doi:10.1073/pnas.0810934106. PubMed: 19174508.
32. Vila L, Barrett EF, Barrett JN, (2003) Stimulation-induced mitochondrial [Ca2+] elevations in mouse motor terminals: comparison of wild-type with SOD1-G93A. J Physiol 549: 719-728. doi:10.1113/jphysiol.2003.041905. PubMed: 12717010.
33. Zhou J, Yi J, Fu R, Liu E, Siddique T, et al. (2010) Hyperactive intracellular calcium signaling associated with localized mitochondrial defects in skeletal muscle of an animal model of amyotrophic lateral sclerosis. J Biol Chem 285: 705-712. doi:10.1074/jbc.M109.041319. PubMed: 19889637.
34. Pagani MR, Reisin RC, Uchitel OD, (2006) Calcium signaling pathways mediating synaptic potentiation triggered by amyotrophic lateral sclerosis IgG in motor nerve terminals. J Neurosci 26: 2661-2672. doi:10.1523/JNEUROSCI.4394-05.2006. PubMed: 16525045.
35. Gundersen K, (1990) Spontaneous activity at long-term silenced synapses in rat muscle. J Physiol 430: 399-418. PubMed: 1707969.
36. Miledi R, (1960) Properties of regenerating neuromuscular synapses in the frog. J Physiol 154: 190-205. PubMed: 13770626.
37. Birks R, Katz B, Miledi R, (1960) Physiological and structural changes at the amphibian myoneural junction, in the course of nerve degeneration. J Physiol 150: 145-168. PubMed: 13800902.
38. Weinstein SP, (1980) A comparative electrophysiological study of motor end-plate diseased skeletal muscle in the mouse. J Physiol 307: 453-464. PubMed: 7205674.
39. Fischer LR, Culver DG, Tennant P, Davis AA, Wang M, et al. (2004) Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp Neurol 185: 232-240. doi:10.1016/j.expneurol.2003.10.004. PubMed: 14736504.
40. Tateno M, Kato S, Sakurai T, Nukina N, Takahashi R, et al. (2009) Mutant SOD1 impairs axonal transport of choline acetyltransferase and acetylcholine release by sequestering KAP3. Hum Mol Genet 18: 942-955. PubMed: 19088126.
41. Narai H, Manabe Y, Nagai M, Nagano I, Ohta Y, et al. (2009) Early detachment of neuromuscular junction proteins in ALS mice with SODG93A mutation. Neurol Int 1: e16. PubMed: 21577353.
42. Ruiz R, Casañas JJ, Torres-Benito L, Cano R, Tabares L, (2010) Altered intracellular Ca2+ homeostasis in nerve terminals of severe spinal muscular atrophy mice. J Neurosci 30: 849-857. doi:10.1523/JNEUROSCI.4496-09.2010. PubMed: 20089893.
43. Atkin JD, Scott RL, West JM, Lopes E, Quah AK, et al. (2005) Properties of slow- and fast-twitch muscle fibres in a mouse model of amyotrophic lateral sclerosis. Neuromuscul Disord, 15: 377-388. doi:10.1016/j.nmd.2005.02.005. PubMed: 15833433.
44. Rowe RW, Goldspink G, (1969) Muscle fibre growth in five different muscles in both sexes of mice. J Anat 104: 519-530. PubMed: 5804561.
45. Schaefer AM, Sanes JR, Lichtman JW, (2005) A compensatory subpopulation of motor neurons in a mouse model of amyotrophic lateral sclerosis. J Comp Neurol 490: 209-219. doi:10.1002/cne.20620. PubMed: 16082680.
46. Valdez G, Tapia JC, Lichtman JW, Fox MA, Sanes JR, (2012) Shared resistance to aging and ALS in neuromuscular junctions of specific muscles. PLOS ONE 7: e34640. doi:10.1371/journal.pone.0034640. PubMed: 22485182.
47. Kretschmannová K, Zemková H, (2004) Characterization of neuromuscular transmission in mice with progressive motoneuronopathy. Physiol Res 53: 541-548. PubMed: 15479133.
48. de Carvalho M, (2000) Pathophysiological significance of fasciculations in the early diagnosis of ALS. Amyotroph Lateral Scler Other Mot Neuron Disord, 1 (Suppl 1):: S43-S46. doi:10.1080/14660820050515539. PubMed: 11464925.
49. Courtney J, Steinbach JH, (1981) Age changes in neuromuscular junction morphology and acetylcholine receptor distribution on rat skeletal muscle fibres. J Physiol 320: 435-447. PubMed: 7320945.
50. Personius KE, Sawyer RP, (2006) Variability and failure of neurotransmission in the diaphragm of mdx mice. Neuromuscul Disord 16: 168-177. doi:10.1016/j.nmd.2006.01.002. PubMed: 16483776.